| Title: | Multi-task deep learning for risk stratification and shared molecular architecture of cardiometabolic multimorbidity under fragmented multi-omics |
| Journal: | BMC Bioinformatics |
| Published: | 24 Aug 2026 |
| DOI: | https://doi.org/10.1186/s12859-026-06614-w |
| URL: | http://dx.doi.org/10.1186/s12859-026-06614-w |
Publication 20921
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Cardiometabolic multimorbidity (CMM) reflects a systemic failure of interconnected physiological networks, yet current risk stratification approaches based on macroscopic clinical phenotypes leave substantial molecular residual risk unresolved. Although multi-omics integration offers a means to capture this latent vulnerability, its population-scale application is limited by pervasive fragmentation and non-overlapping availability of proteomic and metabolomic data. Here, we develop the Multi-Omics Perceiver for Survival (MOP-Surv), a deep learning framework designed to accommodate incomplete multi-omics profiles without imputation through dynamic attention masking and multi-task survival learning. Applied to 297,067 UK Biobank participants, MOP-Surv achieved consistent risk stratification across six cardiometabolic endpoints and provided modest incremental predictive value. Beyond prediction, MOP-Surv identified a hierarchical structure of cross-endpoint prognostic associations and highlighted a parsimonious set of biomarkers including GDF15, EDA2R, and WFDC2 with consistent prognostic relevance across diverse disease trajectories. Therefore MOP-Surv provides a practical approach for integrating fragmented multi-omics data to characterize shared prognostic patterns across cardiometabolic outcomes.</p>
8 Authors
- Liangshen Cao
- Jianing Wang
- Shuaihong You
- Xinran Qiao
- Guangying Yue
- Xiaole Zhu
- Liyuan Han
- Hongpeng Sun
1 Application
| Application ID | Title |
|---|---|
| 78619 | Comprehensive investigation into the relationship of genetic and environmental factors with metabolic diseases and cancer |
Enabling scientific discoveries that improve human health